{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:15Z","timestamp":1786980255431,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T00:00:00Z","timestamp":1487894400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00467-017-3619-2","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T07:17:25Z","timestamp":1487920645000},"page":"1023-1028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["C3 glomerulopathy and eculizumab: a report on four paediatric cases"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0566-2658","authenticated-orcid":false,"given":"C\u00e9lia","family":"Lebreton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Dijoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Bessenay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fremeaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Laure","family":"Sellier-Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,24]]},"reference":[{"key":"3619_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMra1108178","volume":"366","author":"S Sethi","year":"2012","unstructured":"Sethi S, Fervenza FC (2012) Membranoproliferative glomerulonephritis\u2014a new look at an old entity. N Engl J Med 366:1119\u20131131","journal-title":"N Engl J Med"},{"key":"3619_CR2","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrneph.2012.213","volume":"8","author":"AS Bomback","year":"2012","unstructured":"Bomback AS, Appel GB (2012) Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol 8:634\u2013642","journal-title":"Nat Rev Nephrol"},{"key":"3619_CR3","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1097\/MPH.0b013e318258079a","volume":"34","author":"T Bauters","year":"2012","unstructured":"Bauters T, Bordon V, Robays H, Benoit Y, Dhooge C (2012) Successful use of eculizumab in a pediatric patient treated for paroxysmal nocturnal hemoglobinuria. J Pediatr Hematol Oncol 34:e346\u2013e348","journal-title":"J Pediatr Hematol Oncol"},{"key":"3619_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1053\/j.ajkd.2013.07.011","volume":"63","author":"F Fakhouri","year":"2014","unstructured":"Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Ch\u00e2telet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Fr\u00e9meaux-Bacchi V (2014) Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases. Am J Kidney Dis 63:40\u201348","journal-title":"Am J Kidney Dis"},{"key":"3619_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000368592","volume":"128","author":"AS Bomback","year":"2014","unstructured":"Bomback AS (2014) Eculizumab in the treatment of membranoproliferative glomerulonephritis. Nephron Clin Pract 128:270\u2013276","journal-title":"Nephron Clin Pract"},{"key":"3619_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ki.2012.63","volume":"82","author":"A Servais","year":"2012","unstructured":"Servais A, No\u00ebl LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Gr\u00fcnfeld JP, Niaudet P, Lesavre P, Fr\u00e9meaux-Bacchi V (2012) Acquired and genetic complement abdnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82:454\u2013464","journal-title":"Kidney Int"},{"key":"3619_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nrneph.2015.54","volume":"11","author":"J Bacchetta","year":"2015","unstructured":"Bacchetta J, Cochat P (2015) Primary disease recurrence-effects on paediatric renal transplantation outcomes. Nat Rev Nephrol 11:371\u2013384","journal-title":"Nat Rev Nephrol"},{"key":"3619_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/ndt\/gfs549","volume":"28","author":"KJ Stralen Van","year":"2013","unstructured":"Van Stralen KJ, Verrina E, Belingheri M, Dudley J, Dusek J, Grenda R, Macher MA, Puretic Z, Rubic J, Rudaitis S, Rudin C, Schaefer F, Jager KJ (2013) Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population. Nephrol Dial Transplant 28:1031\u20131038","journal-title":"Nephrol Dial Transplant"},{"key":"3619_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00467-013-2605-6","volume":"29","author":"C Nicolas","year":"2014","unstructured":"Nicolas C, Vuiblet V, Baudouin V, Macher MA, Vrillon I, Biebuyck-Gouge N, Dehennault M, Gie S, Morin D, Nivet H, Nobili F, Ulinski T, Ranchin B, Marinozzi MC, Ngo S, Fremeaux-Bacchi V, Pietrement C (2014) C3 nephritic factor associated with C3 glomerulopathy in children. Pediatr Nephrol 29:85\u201394","journal-title":"Pediatr Nephrol"},{"key":"3619_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/nep.12382","volume":"20","author":"Y Okuda","year":"2015","unstructured":"Okuda Y, Ishikura K, Hamada R, Harada R, Sakai T, Hamasaki Y, Hataya H, Fukuzawa R, Ogata K, Honda M (2015) Membranoproliferative glomerulonephritis and C3 glomerulonephritis : frequency, clinical features, and outcome in children. Nephrology 20:286\u2013292","journal-title":"Nephrology"},{"key":"3619_CR11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMc1111953","volume":"366","author":"M Vivarelli","year":"2012","unstructured":"Vivarelli M, Pasini A, Emma F (2012) ECULIZUMAB for the treatment of dense deposit disease. N Engl J Med 366:1163\u20131165","journal-title":"N Engl J Med"},{"key":"3619_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00467-008-1023-7","volume":"24","author":"S De","year":"2009","unstructured":"De S, Al-Nabhani D, Thorner P, Cattran D, Piscione TD, Licht C (2009) Remission of resistant MPGN type I with mycophenolate mofetil and steroids. Pediatr Nephrol 24:597\u2013600","journal-title":"Pediatr Nephrol"},{"key":"3619_CR13","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/ki.2015.227","volume":"88","author":"C Rabasco","year":"2015","unstructured":"Rabasco C, Cavero T, Rom\u00e1n E, Rojas-Rivera J, Olea T, Espinosa M, Cabello V, Fern\u00e1ndez-Juarez G, Gonz\u00e1lez F, \u00c1vila A, Baltar JM, D\u00edaz M, Alegre R, El\u00edas S, Ant\u00f3n M, Frutos MA, Pobes A, Blasco M, Mart\u00edn F, Bernis C, Mac\u00edas M, Barroso S, de Lorenzo A, Ariceta G, L\u00f3pez-Mendoza M, Rivas B, L\u00f3pez-Revuelta K, Campistol JM, Mendiz\u00e1bal S, de C\u00f3rdoba SR, Praga M, Spanish Group for the Study of Glomerular Diseases (GLOSEN) (2015) Effectiveness of mycophenolate mofetil in C3 glomerulonephritis. Kidney Int 88:1153\u20131160","journal-title":"Kidney Int"},{"key":"3619_CR14","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00467-013-2711-5","volume":"29","author":"C Rousset-Rouvi\u00e8re","year":"2014","unstructured":"Rousset-Rouvi\u00e8re C, Cailliez M, Garaix F, Bruno D, Laurent D, Tsimaratos M (2014) Rituximab fails where eculizumab restores renal function in C3nef related DDD. Pediatr Nephrol 29:1107\u20131111","journal-title":"Pediatr Nephrol"},{"key":"3619_CR15","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.transproceed.2012.09.038","volume":"44","author":"F Gonz\u00e1lez-Roncero","year":"2012","unstructured":"Gonz\u00e1lez-Roncero F, Su\u00f1er M, Bernal G, Cabello V, Toro M, Pereira P, Angel Gentil M (2012) Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: case reports. Transplant Proc 44:2690\u20132694","journal-title":"Transplant Proc"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3619-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3619-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3619-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T12:10:16Z","timestamp":1492690216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3619-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,24]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["3619"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3619-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,24]]}}}